Condiciones de salud que Propóleo puede ayudar a apoyar.
Propolis (bee glue) has well-documented antibacterial properties against C. acnes and has been evaluated in double-blind RCTs for acne. A 30-day double-blind RCT using a propolis–tea tree oil–aloe vera cream vs. erythromycin demonstrated comparable or superior reductions in total lesion counts and acne severity. Its bioactive constituents include flavonoids and phenolic acids with anti-inflammatory activity.
Propolis (bee propolis) contains caffeic acid phenethyl ester (CAPE) and artepillin C, which have potent NF-κB inhibitory and antioxidant effects in vascular endothelial cells. Multiple studies demonstrate propolis reduces LDL oxidation, inhibits platelet aggregation, and reduces arterial inflammation. RCTs show improvements in lipid profiles and inflammatory markers relevant to atherosclerosis.
Propolis is a resinous honeybee product with documented in vitro antifungal activity against dermatophytes including Trichophyton species. Small clinical studies have shown propolis extracts can treat fungal nail infections, and it appears as an active ingredient in some OTC antifungal formulations. Lab studies confirm antifungal properties relevant to tinea pedis; human RCT evidence specific to tinea pedis is limited.
Bee propolis and its bioactive compounds (artepillin C, caffeic acid phenethyl ester/CAPE, flavonoids) have demonstrated immunomodulatory effects in autoimmune conditions including RA and IBD. CAPE inhibits NF-κB and reduces pro-inflammatory cytokines. Clinical and preclinical evidence supports anti-inflammatory and immune-balancing effects.
Propolis, a bee-derived resinous substance, has documented antimicrobial, anti-inflammatory, antioxidant, and wound-healing properties with preclinical and some clinical evidence for burns. Animal studies confirm propolis stimulates glycosaminoglycan remodeling in burn wounds superior to silver sulfadiazine. Propolis nano-emulsion achieved 98.13% wound contraction at day 14 in a rat second-degree burn model and improved epithelialization, fibrosis, and angiogenesis.
Propolis is a resinous hive product from bees with broad-spectrum antifungal activity against multiple Candida species confirmed across multiple in vitro studies from diverse geographic sources. It inhibits C. albicans germ tube formation and growth. Multiple reviews confirm consistent anti-Candida activity, and it is recognized in integrative Candida protocols.
Bee propolis, a resinous compound produced by honeybees containing flavonoids and caffeic acid phenethyl ester (CAPE), has demonstrated antifungal activity against Candida albicans in multiple in vitro studies by disrupting the fungal cell membrane. Brazilian and other regional propolis types have been documented for anti-Candida efficacy. It is included in some Candida cleanse protocols.
Propolis is a resin-like substance collected by honeybees with documented antimicrobial and immunomodulatory properties. Clinical trials have shown propolis reduces the incidence and duration of upper respiratory tract infections, including in children. It exerts broad-spectrum antiviral and antibacterial activity alongside stimulation of macrophage and NK cell activity.
Bee propolis has been used in traditional medicine across cultures for energy and vitality, with modern research showing anti-inflammatory and antioxidant properties that address fatigue pathophysiology. Brazilian green propolis (artepillin C) has been studied for immune support and fatigue reduction, particularly in cancer-related fatigue contexts.
Bee propolis has demonstrated antiviral and immunomodulatory activity relevant to cold and flu. A combination RCT found echinacea plus propolis plus vitamin C significantly reduced respiratory infection frequency in children vs. placebo. Propolis flavonoids and caffeic acid derivatives show antiviral activity against influenza viruses and rhinovirus in vitro. ConsumerLab and EBSCO list propolis among cold and flu supplements.
Propolis is a resinous bee product with multiple RCTs demonstrating efficacy against herpes labialis at least equivalent, and often superior, to acyclovir 5% cream. A 2025 systematic review and a 2026 meta-analysis confirmed propolis as one of the strongest herbal interventions for herpes labialis, with demonstrated shorter healing times and better symptom resolution compared to acyclovir in several trials.
Propolis (bee propolis) has clinical evidence for atopic dermatitis. Artepillin C and other polyphenols in propolis exhibit anti-inflammatory activity, and propolis-tea tree oil-aloe vera cream (PTAC) has been tested in AD clinical studies. Propolis has traditional use across diverse cultures for inflammatory skin conditions.
Bee propolis has demonstrated anti-inflammatory, antioxidant, and immunomodulatory properties evaluated in endometriosis. A single RCT confirmed propolis supplementation was effective in reducing endometriosis-related pain. Propolis contains bioactive compounds including flavonoids, phenolic acids, and Artepillin C with direct anti-inflammatory activity.
Propolis, a resinous bee-derived substance, has demonstrated antifungal activity against Candida species, Trichophyton mentagrophytes, T. tonsurans, and other dermatophytes in multiple in vitro studies. A PMC study (Frontiers in Microbiology 2018) assessed ethanol propolis extract for onychomycosis from bench to clinical application with positive antifungal outcomes. Brazilian red propolis shows activity against Trichophyton species responsible for dermatophytosis. Its antifungal components include flavonoids, terpenoids, and phenolic compounds.
Propolis has demonstrated direct anti-H. pylori bactericidal activity in vitro and in clinical studies, including activity against antibiotic-resistant strains. A 2014 World Journal of Gastroenterology review of natural treatments for H. pylori infection identified propolis as one of the natural agents with clinical research evidence. Its principal constituents include CAPE and flavonoids with anti-inflammatory and antibacterial actions.
Propolis is a bee-derived resin rich in flavonoids (pinocembrin, galangin, caffeic acid phenethyl ester) with potent antioxidant, anti-inflammatory, and antimicrobial properties. Multiple human RCTs demonstrate propolis reduces inflammatory biomarkers, improves glycemic control, and supports immune function in adults — all highly relevant to healthy aging.
Propolis, a resinous bee-derived substance, has shown virucidal activity against both HSV-1 and HSV-2 in vitro, including acyclovir-resistant strains. Multiple clinical trials support topical 3% propolis ointment for herpes labialis and genitalis, with one RCT showing healing in 6.24 vs. 9.77 days vs. placebo. A 2026 meta-analysis of 7 RCTs found propolis/honey outperformed 5% acyclovir cream for lesion resolution.
Bee propolis contains antimicrobial flavonoids (galangin, pinocembrin) and phenolic acids (caffeic acid, ferulic acid) with documented activity against oral microbiome pathogens including S. mutans, E. faecalis, and oral Candida. In vitro studies confirm inhibition of cariogenic and periodontopathic species. A clinical toothpaste RCT combining propolis and tea tree oil demonstrated stabilization of oral bacterial microflora.
Bee propolis has demonstrated antiparasitic activity in vitro against Giardia lamblia, Toxoplasma gondii, and Leishmania species, and is listed by EBSCO Research Starters among traditional herbs proposed for intestinal parasite treatment.
A resinous substance produced by bees, propolis (bee propolis) has documented antimicrobial, antiviral, and immunostimulatory properties. Clinical evidence shows propolis reduces duration and severity of respiratory infections. It contains flavonoids and caffeic acid esters that modulate innate immunity, supporting post-illness recovery.
Propolis has been tested in an RCT as adjunct treatment for hospitalized COVID-19 patients and shown antiviral and immunomodulatory activity in both preclinical and clinical studies. A 2022 PMC systematic review confirmed propolis has broad-spectrum antiviral effects in vitro/in vivo and modulates cytokine production relevant to post-viral recovery. It has been proposed to reduce inflammatory processes by PAK1 inhibition.
Bee propolis has documented antimicrobial and antibiofilm activity against bacteria isolated from patients with chronic rhinosinusitis. A 2023 in vitro study (PMC 10674846) showed NAC/propolis combinations effective against biofilms from chronic sinusitis pathogens. Traditional use across cultures for respiratory infections is established.
Bee propolis has direct randomized controlled trial evidence for sore throat. A monocentric, double-blind, placebo-controlled RCT (Esposito et al., 2020, n=122 adults) found a standardized propolis oral spray produced significantly greater remission of sore throat, muffled voice, and throat swelling than placebo in mild upper respiratory tract infections. A PMC systematic review confirmed clinical benefit for respiratory viral disease symptoms.
Propolis has direct clinical evidence for tonsillopharyngitis treatment in children. An open-label RCT (n=130 children) using a supplement with honey, propolis, Pelargonium sidoides, and zinc showed significantly improved tonsillitis severity scores versus standard care alone. A 2004 RCT demonstrated >50% reduction in tonsillopharyngitis incidence with an echinacea-propolis-vitamin C combination. Propolis is active against Streptococcus pyogenes strains.
Propolis, a resinous bee product rich in flavonoids and phenolic acids, has been investigated for tooth remineralization. In vitro studies show that propolis oil enhances enamel microhardness after demineralization, and propolis-enriched xylitol chewing gum enhances intrafibrillar biomineralization of demineralized dentin. Propolis also inhibits cariogenic bacteria, reducing acid-driven demineralization.
Bee propolis has demonstrated gastroprotective activity in rodent models of NSAID-induced gastric ulcers, reducing ulcer index and myeloperoxidase activity. Artepillin C and flavonoids (galangin, caffeic acid phenethyl ester) in propolis inhibit xanthine oxidase and reduce neutrophil infiltration in gastric mucosa. It is listed among proposed natural treatments for gastritis/ulcer in EBSCO Research Starters.
Bee propolis is a resinous mixture with documented broad-spectrum antiviral activity in vitro, in vivo, and in preliminary clinical trials. Key bioactives including quercetin, kaempferol, apigenin, caffeic acid, and chrysin inhibit SARS-CoV-2 spike-ACE2 interaction, reduce viral RNA synthesis, and modulate cytokine production. Multiple in vitro and clinical studies support respiratory antiviral applications.
Propolis (bee propolis) is a resinous hive substance with well-documented antibacterial, anti-inflammatory, and wound-healing properties confirmed by multiple preclinical studies and some clinical trials. It shortens healing time, reduces scar formation, promotes wound contraction, and stimulates epithelialization.
Propolis is a resinous beehive product used in traditional medicine across many cultures for oral antisepsis and breath improvement. It contains flavonoids, phenolic acids, and caffeic acid esters with documented antimicrobial activity against oral pathogens. Traditional use for halitosis is documented in Middle Eastern, Eastern European, and Brazilian folk medicine. Some in vitro studies confirm propolis inhibits Streptococcus mutans and other oral anaerobes relevant to bad breath.
Bee propolis has traditional use across Mediterranean and Eastern European folk medicine for throat infections and upper respiratory conditions. Its polyphenols (CAPE, galangin, quercetin) demonstrate antimicrobial, antiviral, and anti-inflammatory activities. Some clinical evidence supports reduction in URTI incidence and severity in children.